Mammalian-targeted antiviral peptide reduces dengue virus type 1 infection in Aedes aegypti. - Medina-Carrasco D; Santiago GC; Garay Pérez HE; Gutiérrez-Bugallo G; González-Lodeiro LG; Vega-Rúa A; Galindo VH (Antiviral research, 2025)